Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1987-12-9
|
pubmed:abstractText |
The 2,3-bis[[(N-methylcarbamoyl)oxy]methyl]-3-pyrroline 1-oxide 5 was synthesized and tested in the murine P388 lymphocytic leukemia model. The compound showed significant reproducible activity and was more potent than indicine N-oxide. 1-Methyl-2-phenyl-3,4-bis[[(N-2- propylcarbamoyl)oxy]methyl]-3-pyrroline N-oxide (6) was less active than 5, and the 5,5-dimethyl analogue of 6, the pyrroline N-oxide 7, was inactive. The N-oxide 7 cannot be converted to a pyrrole in vivo because of the gem-dimethyl substitution at C-5.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2144-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3669020-Animals,
pubmed-meshheading:3669020-Antineoplastic Agents,
pubmed-meshheading:3669020-Leukemia P388,
pubmed-meshheading:3669020-Mice,
pubmed-meshheading:3669020-Pyrroles,
pubmed-meshheading:3669020-Pyrrolizidine Alkaloids,
pubmed-meshheading:3669020-Structure-Activity Relationship
|
pubmed:year |
1987
|
pubmed:articleTitle |
3-Pyrroline N-oxide bis(carbamate) tumor inhibitors as analogues of indicine N-oxide.
|
pubmed:affiliation |
Department of Medicinal Chemistry, School of Pharmacy, State University of New York at Buffalo 14260.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|